Natera director sells shares under 10b5-1 plan
Natera, Inc. director Rowan E Chapman sold 135 shares of Common Stock on July 15, 2026 at an average price of $274.82 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Natera, Inc. director Rowan E Chapman sold 135 shares of Common Stock on July 15, 2026 at an average price of $274.82 per share. The sale was effected under a Rule 10b5-1 trading plan adopted on December 12, 2025, leaving Chapman with 4,663 shares held directly.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 135 | $274.82 | $37K |
Footnotes (1)
- F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open market or private transaction financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Natera (NTRA) report on July 15, 2026?
Was the Natera (NTRA) insider sale by Rowan E Chapman under a Rule 10b5-1 plan?
What type of security was involved in the Natera (NTRA) insider transaction?
How is the Natera (NTRA) insider sale by Rowan E Chapman classified?
AI-generated analysis. How Rhea-AI works. Not financial advice.